Supplemental material
Report
Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform
Torben GjettingAntibody Discovery, Antibody Discovery, Ballerup, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0003-1720-474X
https://orcid.org/0000-0003-1720-474X, , Camilla FröhlichAntibody Pharmacology, Symphogen A/S, Ballerup, Denmarkhttps://orcid.org/0000-0001-8391-2416
https://orcid.org/0000-0001-8391-2416, , , , Michael M GrandalCancer Biology and Immunology, Symphogen A/S, Ballerup, Denmarkhttps://orcid.org/0000-0001-5434-9978
https://orcid.org/0000-0001-5434-9978, Nikolaj DietrichAntibody Discovery, Antibody Discovery, Ballerup, Denmarkhttps://orcid.org/0000-0002-3477-0922
https://orcid.org/0000-0002-3477-0922, , , Magnus StrandhAntibody Discovery, Antibody Discovery, Ballerup, Denmarkhttps://orcid.org/0000-0002-6878-1566
https://orcid.org/0000-0002-6878-1566, Johan LanttoGlobal Research and Development, Symphogen A/S, Ballerup, Denmarkhttps://orcid.org/0000-0002-8650-7157
https://orcid.org/0000-0002-8650-7157, Thomas BouquinAntibody Discovery, Antibody Discovery, Ballerup, Denmarkhttps://orcid.org/0000-0002-9597-8137
https://orcid.org/0000-0002-9597-8137, , , Mikkel W PedersenCancer Biology and Immunology, Symphogen A/S, Ballerup, Denmarkhttps://orcid.org/0000-0001-5711-9051
https://orcid.org/0000-0001-5711-9051 & Klaus KoefoedAntibody Discovery, Antibody Discovery, Ballerup, Denmarkhttps://orcid.org/0000-0001-8945-3791
https://orcid.org/0000-0001-8945-3791 show all